Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond
about
RNA-virus proteases counteracting host innate immunity.Escape of tick-borne flavivirus from 2' -C-methylated nucleoside antivirals is mediated by a single conservative mutation in NS5 that has a dramatic effect on viral fitness.Modulation of Lipid Droplet Metabolism-A Potential Target for Therapeutic Intervention in Flaviviridae Infections.The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design.Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo.Structure and function of Zika virus NS5 protein: perspectives for drug design.Pharmacological Inhibition of Protein Kinase C Reduces West Nile Virus Replication.Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses.Direct Activation of Adenosine Monophosphate-Activated Protein Kinase (AMPK) by PF-06409577 Inhibits Flavivirus Infection through Modification of Host-Cell Lipid Metabolism.The Antiviral Drug Arbidol Inhibits Zika Virus.Development and validation of a phenotypic high-content imaging assay for assessing the antiviral activity of small-molecule inhibitors targeting the Zika virusEstablishment of Baculovirus-Expressed VLPs Induced Syncytial Formation Assay for Flavivirus Antiviral ScreeningChallenges and recent progress in drug discovery for tropical diseasesThe Role of Host Cholesterol During Flavivirus Infection
P2860
Q40066626-E90492C0-0A84-4832-B4F9-3DE635FE75E5Q40080931-6BC23106-490A-47F1-97AF-AF9F346E1028Q47104952-9E58116A-BA4C-458D-A8C4-00E2539BC011Q47558217-3BFB6F59-1B1C-4068-9961-631A0268C6D4Q47558474-46F4B229-8983-4D8A-A672-AF91C3E2F70CQ48504896-22EE0CC4-1DAB-4A44-956B-3F67429F6258Q51336673-A9167231-20DF-4486-B64E-754A0CBEB029Q54256710-1BFE627A-E2DC-4536-9A8A-AE7A04FD297BQ54558540-67F2F303-F32C-4CF6-8E88-A01B88283D91Q55084371-56145A65-EEBC-453F-82EF-CF9751046348Q56342513-C0867D4D-CC4D-4471-B014-816230C62D6CQ56347959-A2D61293-744C-4EBF-9621-5E0A3D2927EEQ59073293-AE960D12-AB6D-4EEC-AF89-7BB6400FD97FQ59132140-1F0496BD-8EEE-4D86-9B10-CAB475E4A825
P2860
Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond
@ast
Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond
@en
type
label
Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond
@ast
Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond
@en
prefLabel
Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond
@ast
Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond
@en
P2860
P50
P921
P356
P1476
Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond
@en
P2093
Mira A M Behnam
P2860
P2888
P304
P356
10.1038/NRD.2017.33
P407
P577
2017-05-05T00:00:00Z
P6179
1085173815